Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2010;3(2):35. doi: 10.1038/scibx.2010.35

Giving RSV some POP(G)

Tracey Baas
PMCID: PMC7149077

Abstract

National Jewish Health researchers have shown that a low-cost pulmonary surfactant inhibits binding of respiratory syncytial virus to lung epithelial surfaces. Although issues related to both prophylactic and treatment applications need to be worked out, the researchers believe the path to human trials could be relatively short.

Footnotes

The online version of the original article can be found at 10.1038/scibx.2010.90


Articles from Science-Business eXchange are provided here courtesy of Nature Publishing Group

RESOURCES